This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Oral Amantadine, IV Amantadine and Hemodynamic Response to Laryngoscopy

Sponsored by Assiut University

About this trial

Last updated 4 years ago

Study ID

17300205

Status

Unknown status

Type

Interventional

Phase

Phase 2

Placebo

No

Accepting

18-75 Years
18 to 55 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 3 years ago

What is this trial about?

this study will be undertaken-to evaluate the effect of oral amantadine versus IV amantadine premedication on the hemodynamic response to laryngoscopy ,tracheal intubation and surgical incision and their effect on β-endorphins.

What are the participation requirements?

Yes

Inclusion Criteria

- ASA I&II

- the age range 20-55 years scheduled for elective back surgery(laminectomy, discectomy and spinal canal stenosis)

No

Exclusion Criteria

- Patient refusal

- Patients with ASA score III (with chronic kidney, lungs, Gastrointestinal tract, liver, or cardiovascular diseases)

- Pregnant or breastfeeding women.

- Allergy to any of the study medications and taking medications that could significantly interact with amantadine (tramadol, atropine, antipsychotic medications)

- DM, thyroid disease any endocrine disease

- Suspected difficult intubation or intubation time more than 30 second.

Locations

Location

Status

Recruiting